<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04506476</url>
  </required_header>
  <id_info>
    <org_study_id>OnkoFit I</org_study_id>
    <nct_id>NCT04506476</nct_id>
  </id_info>
  <brief_title>Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer</brief_title>
  <acronym>OnkoFit I</acronym>
  <official_title>Randomisierte Studie Zum Nutzen Des Fitnesstracker Basierten Aktivitätstrainings während Einer Adjuvanten Bestrahlung Des Mammakarzinoms (OnkoFit I)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized three-arm trial will test the benefit in terms of cancer related fatigue of&#xD;
      an activity tracker based exercise training during adjuvant radiotherapy in breast cancer&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This monocentric, three-arm, randomized, controlled clinical trial evaluates the effect of an&#xD;
      activity tracker based exercise program in breast cancer patients on the fatigue syndrome&#xD;
      during adjuvant radiotherapy. Quality of Life and the intensity of fatigue will be documented&#xD;
      with the fatigue subscale of the FACIT Questionnaire three months after adjuvant&#xD;
      radiotherapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the impact of an activity tracker based fitness programme on the fatigue syndrome</measure>
    <time_frame>3 Months after completion of adjuvant radiotherapy of breast cancer</time_frame>
    <description>This endpoint will be evaluated by the FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue) subscale of the FACIT questionnaire (Physical well-being values 0-28, 28 worse outcome; social/family well-being values 0-28, 28 better outcome; emotional well-being values 0-24, 24 worse outcome; functional well being values 0-28, 28 better outcome; additional factors values 0-64, 64 worse outcome</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">201</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Activity tracker with weekly goals</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive a fitness tracker, a booklet &quot;Physical training, exercise and cancer&quot; and an in-person briefing on physical activity during cancer therapy. We suggest a daily step-count which should improve the patients physical activity during radiotherapy of breast cancer. Patients receive weekly feedback and a new goal with the aim to reach a total of 6000 daily steps, which should be then maintained during radiotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Activity tracker without Weekly goals</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive a fitness tracker, a booklet &quot;Physical training, exercise and cancer&quot; and an in-person briefing on physical activity during cancer therapy.&#xD;
The patients self-document their daily step count during radiotherapy, there will be no recommendation for the daily count of steps.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm with no activity tracker</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receive a booklet &quot;Physical training, exercise and cancer&quot; and an in-person briefing on physical activity during cancer therapy. A fitness tracker will not be provided.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fitness tracker based activity training for Arm A and B. Booklet &quot;physical training, exercise and cancer&quot; and an introduction about physical activity during cancer therapy for Arm A, B, C</intervention_name>
    <description>Patients receive a fitness tracker, a booklet &quot;Physical training, exercise and cancer&quot; and an in-person briefing about physical activity during cancer therapy. With offered guidelines for the daily step counts patients should improve their physical activity during radiotherapy of breast cancer. A weekly feedback and a new goal for the next week will be provided until the individual patient reaches a daily activity of 6000 steps. The setting will be to maintain to this daily activity of 6000 steps during radiotherapy.</description>
    <arm_group_label>Activity tracker with weekly goals</arm_group_label>
    <arm_group_label>Activity tracker without Weekly goals</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Capacity for consent&#xD;
&#xD;
          -  Minimum age 18&#xD;
&#xD;
          -  Presence of breast cancer&#xD;
&#xD;
          -  ECOG 0-2&#xD;
&#xD;
          -  Indication for adjuvant radiotherapy of breast cancer after breast-conserving surgery&#xD;
             or Ablatio mammae&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participation in any other interventional study&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Contraindication against physical activity/sport and others&#xD;
&#xD;
          -  Severe cardiovascular pre-existing conditions (after myocardial infarction, apoplexy&#xD;
             in the last 6 months, congestive heart failure NYHA &gt; I°)&#xD;
&#xD;
          -  preexisting diseases with are relevantly accompanied by a limited mobility in patients&#xD;
             (e.g. paraparesis of the lower limbs)&#xD;
&#xD;
          -  ECOG Status 3-4&#xD;
&#xD;
          -  prior use of activity trackers&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cihan Gani, MD, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tübingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cihan Gani, MD, PD</last_name>
    <phone>+49 (0) 7071 29-82165</phone>
    <email>cihan.gani@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Zips, MD, Prof</last_name>
    <phone>+49 (0) 7071 29-82165</phone>
    <email>ro-info@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Tübingen, Department of Radiation Oncology</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Zips, MD, Prof</last_name>
      <phone>+49 (0) 7071 29-85990</phone>
      <email>ro-info@med.uni-tuebingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Cihan Gani, MD</last_name>
      <phone>+49 (0)7071 29-82165</phone>
      <email>cihan.gani@med.uni-tuebingen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 6, 2020</study_first_submitted>
  <study_first_submitted_qc>August 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>August 13, 2020</last_update_submitted>
  <last_update_submitted_qc>August 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Dr. Cihan Gani</investigator_full_name>
    <investigator_title>Senior Physician</investigator_title>
  </responsible_party>
  <keyword>Fatigue</keyword>
  <keyword>activity tracker</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

